APA引文

Shields, R. K., Nguyen, M. H., Chen, L., Press, E. G., Kreiswirth, B. N., & Clancy, C. J. (2018). Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections. Antimicrob Agents Chemother.

Citação norma Chicago

Shields, Ryan K., M. Hong Nguyen, Liang Chen, Ellen G. Press, Barry N. Kreiswirth, and Cornelius J. Clancy. "Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance Among Patients With Carbapenem-Resistant Enterobacteriaceae Infections." Antimicrob Agents Chemother 2018.

MLA引文

Shields, Ryan K., et al. "Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance Among Patients With Carbapenem-Resistant Enterobacteriaceae Infections." Antimicrob Agents Chemother 2018.